These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 583251)

  • 1. [Inhibition of human leukocytes dihydrofolate reductase by triamterene and its metabolites (author's transl)].
    Schalhorn A; Wilmanns W
    Arzneimittelforschung; 1979; 29(9):1409-11. PubMed ID: 583251
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line.
    Schalhorn A; Siegert W; Sauer HJ
    Eur J Clin Pharmacol; 1981; 20(3):219-24. PubMed ID: 7286039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triamterene-induced elevation of dihydrofolate reductase activity in human leukocytes.
    Roberts D; Hall TC
    Biochem Pharmacol; 1968 Mar; 17(3):481-4. PubMed ID: 5242226
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological effects of phase-I- and phase-II-metabolites of triamterene (author's transl)].
    Knauf H; Mutschler E; Völger KD; Wais U
    Arzneimittelforschung; 1978; 28(8):1417-20. PubMed ID: 582409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the effect of triamterene and hydrochlorothiazide on dihydrofolate reductase activity using a new spectrophotometric method.
    Sidhom MB; Velez MR
    J Pharm Biomed Anal; 1989; 7(12):1551-7. PubMed ID: 2490542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of dihydrofolate reductase by inhibitors in vivo and in vitro.
    Hillcoat BL; Marshall L; Gauldie J; Hiebert M
    Ann N Y Acad Sci; 1971 Nov; 186():187-208. PubMed ID: 4332034
    [No Abstract]   [Full Text] [Related]  

  • 7. Trimethoprim-induced elevation of dihydrofolate reductase activity in human leukocytes.
    Martelli MF; Aversa F; Rambotti P; Velardi A
    Enzyme; 1978; 23(3):154-63. PubMed ID: 33039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic investigation of the reaction mechanism of dihydrofolate reductase from L1210 cells.
    McCullough JL; Nixon PF; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():131-42. PubMed ID: 4399849
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levels of sepiapterin reductase and dihydrofolate reductase activites in mammal blood (author's transl)].
    Katoh S; Taketani T; Takikita K; Yamada S
    Josai Shika Daigaku Kiyo; 1974; (3):47-51. PubMed ID: 4536069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the cardiac effects of triamterene and its phase II metabolite p-hydroxytriamterene sulphuric acid ester (author's transl].
    Greeff K; Schuhmacher P
    Arzneimittelforschung; 1979; 29(4):705-6. PubMed ID: 582773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A histochemical study on the dihydrofolate reductase activity in leukemia.
    Onicescu D; Stoica I; Tasca L
    Acta Histochem; 1973; 45(2):214-8. PubMed ID: 4199687
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug interactions: pteridine diuretics and antifols. I. The inhibition of dihydrofolate reductase by analogues of 2,4,7-triaminopteridines.
    Roberts D; Hall TC
    J Clin Pharmacol J New Drugs; 1968; 8(4):217-8. PubMed ID: 5242160
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the diuretic and saluretic activity of p-hydroxytriamterene and methoxytriamterene (author's transl)].
    Vollmer G; Mutschler E; Völger KD
    Arzneimittelforschung; 1981; 31(3):529-30. PubMed ID: 7194678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On histochemical dihydrofolate reductase activity in leukemic leukocytes in vitro.
    Onicescu D; Mischiu L; Taşcă L
    Rev Roum Morphol Embryol; 1974; 19(1):57-63. PubMed ID: 4533119
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of triamterene on folic reductase activity and reproduction in the rat.
    Maass AR; Wiebelhaus VD; Sosnowski G; Jenkins B; Gessner G
    Toxicol Appl Pharmacol; 1967 May; 10(3):413-23. PubMed ID: 4293862
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
    Bertino JR; Cashmore AR; Hillcoat BL
    Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
    Kao TT; Wang KC; Chang WN; Lin CY; Chen BH; Wu HL; Shi GY; Tsai JN; Fu TF
    Drug Metab Dispos; 2008 Mar; 36(3):508-16. PubMed ID: 18056255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.